Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Griffin Wright"'
Autor:
Kevin J. Lee, Elise Mann, Griffin Wright, Cortt G. Piett, Zachary D. Nagel, Natalie R. Gassman
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: The lack of molecular targets for triple negative breast cancer (TNBC) has limited treatment options and reduced survivorship. Identifying new molecular targets may help improve patient survival and decrease recurrence and metastasis. As
Externí odkaz:
https://doaj.org/article/fd7791141e624ffc9bdf8648e60b7df4
Autor:
Christopher Malozzi, Hannah Bryant, Leigh Ann Wiggins, Michele Schuler, Valeria L Dal Zotto, Griffin Wright, Natalie R. Gassman, Kevin Lee, Michael V. Cohen
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 7439, p 7439 (2021)
Volume 22
Issue 14
International Journal of Molecular Sciences, Vol 22, Iss 7439, p 7439 (2021)
Volume 22
Issue 14
Background: Doxorubicin (Dox) is a first-line treatment for triple negative breast cancer (TNBC), but its use may be limited by its cardiotoxicity mediated by the production of reactive oxygen species. We evaluated whether vitamin D may prevent Dox-i
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 11
International Journal of Molecular Sciences, Vol 22, Iss 5475, p 5475 (2021)
Volume 22
Issue 11
International Journal of Molecular Sciences, Vol 22, Iss 5475, p 5475 (2021)
Base Excision Repair (BER) addresses base lesions and abasic sites induced by exogenous and endogenous stressors. X-ray cross complementing group 1 (XRCC1) functions as a scaffold protein in BER and single-strand break repair (SSBR), facilitating and
Autor:
Natalie R. Gassman, Griffin Wright
Publikováno v:
DNA repair. 93
Base excision repair (BER) addresses the numerous base lesions and strand breaks induced by exogenous and endogenous stressors daily. The complexity and importance of BER requires careful regulation of basal levels of these proteins and inducible res
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background:The lack of molecular targets for triple negative breast cancer (TNBC) has limited treatment options and reduced survivorship. Identifying new molecular targets may help improve patient survival and decrease recurrence and metastasis. As D
Autor:
Leigh Ann Wiggins, Hannah Bryant, Griffin Wright, Michele Schuler, Kevin Lee, Natalie R. Gassman
Publikováno v:
Cancer drug resistance (Alhambra, Calif.). 3(4)
Publikováno v:
Cancer Research. 80:3464-3464
Doxorubicin (Dox) is a first-line treatment for triple negative breast cancer (TNBC), which lacks the molecular targets for hormone or growth factor therapy. Although highly effective as a chemotherapeutic agent, Dox induces severe side effects inclu
Publikováno v:
LCTES
Successive generations of processors use smaller transistors in the quest to make more powerful computing systems. It has been previously studied that smaller transistors make processors more susceptible to soft errors (transient faults caused by hig